Tumor-reactive superantigens suppress tumor growth in humanized scid mice
β Scribed by Peter A. Lando; Mikael Dohlsten; Lennart Ohlsson; Terje Kalland
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 715 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A human Burkitt lymphoma (Daudi) has been grown in the mutant mouse called C.Bβ17 SCID. Twentyβeight days after s.c. injection of Daudi cells, a palpable tumor grew only at the site of injection in all injected mice. In contrast, after intravenous (i.v.) or intraperitoneal (i.p.) inject
## Abstract Malignant cells possess a high degree of proteolytic activity in which the plasminogen activator system plays an important role. An increased expression of urokinase type plasminogen activator (uPA) is of significance for degradation of the extracellular tumor matrix, facilitating invas
## Abstract The lack of efficacy of available therapies for the treatment of malignant melanoma has emphasized the need to develop novel therapeutic strategies to prevent melanoma growth. We have tested whether the antiβHMWβMAA mAb 225.28S is able to inhibit human melanoma tumor growth in SCID mice